These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35903525)

  • 1. Spontaneous adverse drug reaction reporting by community pharmacists: preparedness and barriers.
    Bahlol M; Bushell M; Khojah HMJ; Dewey RS
    Saudi Pharm J; 2022 Jul; 30(7):1052-1059. PubMed ID: 35903525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom.
    Cheema E; Haseeb A; Khan TM; Sutcliffe P; Singer DR
    Pharm Pract (Granada); 2017; 15(3):931. PubMed ID: 28943977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community pharmacists' knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia.
    Khan TM
    Ther Adv Drug Saf; 2013 Apr; 4(2):45-51. PubMed ID: 25083250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.
    Mahmoud MA; Alsowaida Y; Alshammari T; Khan TM; Alrasheedy A; Hassali MA; Aljadhey H
    Saudi Pharm J; 2014 Nov; 22(5):411-8. PubMed ID: 25473329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national survey of knowledge, attitude, practice, and barriers towards pharmacovigilance and adverse drug reaction reporting among hospital pharmacy practitioners in the United Arab Emirates.
    Shanableh S; Zainal H; Alomar M; Palaian S
    J Pharm Policy Pract; 2023 Jul; 16(1):92. PubMed ID: 37464445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
    Li R; Curtain C; Bereznicki L; Zaidi STR
    Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions reporting: a questionnaire-based study on Egyptian pharmacists' attitudes following an awareness workshop.
    Alraie NA; Saad AA; Sabry NA; Farid SF
    J Eval Clin Pract; 2016 Jun; 22(3):349-55. PubMed ID: 26638825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
    Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.
    Vessal G; Mardani Z; Mollai M
    Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacists' attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight.
    Elkalmi RM; Hassali MA; Ibrahim MI; Jamshed SQ; Al-Lela OQ
    J Patient Saf; 2014 Jun; 10(2):81-7. PubMed ID: 24618640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
    Barnes J; Butler R
    Drug Saf; 2020 Nov; 43(11):1157-1170. PubMed ID: 32975740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reaction reporting by community pharmacists-The barriers and facilitators.
    Hughes ML; Weiss M
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1552-1559. PubMed ID: 31131966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs).
    Krska J
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1130-3. PubMed ID: 22729956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Policy Change on Pharmacists' Reporting of Adverse Drug Reactions.
    Roy R; Ma J
    Can J Hosp Pharm; 2018; 71(4):227-233. PubMed ID: 30185996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh.
    Amin MN; Khan TM; Dewan SM; Islam MS; Moghal MR; Ming LC
    BMJ Open; 2016 Aug; 6(8):e010912. PubMed ID: 27489151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' views on adverse drug reactions reporting in Malaysia: a pilot study.
    Ting KN; Stratton-Powell DM; Anderson C
    Pharm World Sci; 2010 Jun; 32(3):339-42. PubMed ID: 20336371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reaction reporting by community pharmacists in the Greater Accra Region of Ghana, 2016.
    Osei JY; Nortey PA; Bandoh DA; Kenu E; Addo-Lartey AA
    Ghana Med J; 2021 Mar; 55(1):9-17. PubMed ID: 38322393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2006; 29(4):331-40. PubMed ID: 16569082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A National Survey of Community Pharmacists' Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia.
    Alsheikh MY; Alasmari MM
    Front Pharmacol; 2022; 13():819551. PubMed ID: 35721182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.